El trading conlleva riesgos
Los CFDs son instrumentos complejos y tienen un alto riesgo de perder dinero rápidamente debido al apalancamiento.
El trading conlleva riesgos
Los CFDs son instrumentos complejos y tienen un alto riesgo de perder dinero rápidamente debido al apalancamiento.
Español (Latinoamérica)
Myomo Inc
Cerrado
0.71 2.9
Resumen
Variación precio
24h
Mínimo
0.64
Máximo
0.72
Ingresos | 969K -3.7M |
|---|---|
Ventas | 1.3M 11M |
Margen de beneficio | -36.3 |
Empleados | 184 |
EBITDA | 968K -2.1M |
Recomendaciones | Compra Fuerte |
|---|---|
Estimación a 12 meses | +332.86% upside |
Próximas Ganancias | 6 may 2026 |
|---|
Capitalización de Mercado | 2.3M 31M |
|---|---|
Apertura anterior | -2.19 |
Cierre anterior | 0.71 |
Myomo Inc Gráfico
El rendimiento pasado no es un indicador fiable de resultados futuros.
Noticias Relacionadas
Comparación entre iguales
Cambio de precio
Myomo Inc Esperado
Precio Objetivo
By TipRanks
332.86% repunte
Estimación a 12 meses
Media 3.03 USD 332.86%
Máximo 5 USD
Mínimo 1.1 USD
De acuerdo con 4 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Myomo Inc Dist en los últimos 3 meses.
Finanzas
Gastos de venta y administración
Gastos operativos
Beneficio antes de impuestos
Ventas
Coste de ventas
Beneficio bruto de ventas
Gasto por intereses de deuda
EBITDA
Beneficio operativo
$
Acerca de Myomo Inc
Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, China, Germany, and internationally. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living. It also provides the MyoPro 2, including control technology, configuration software and user interface, and pop-out battery for extended use of the brace; and MyoPro2+ that comprises 3D printed orthotics capability, software enhancements, and a design for donning and doffing of the device. Its products are designed to help improve function in adults and adolescents with neuromuscular conditions due to brachial plexus injury, stroke, traumatic brain injury, spinal cord injury, and other neurological disorders. The company sells its products through various sales channels, including orthotics and prosthetics providers, the Veterans Administration, and its distributors. Myomo, Inc. was incorporated in 2004 and is headquartered in Boston, Massachusetts.
Live chat